More Articles …

  1. Bridge Biotherapeutics Announces the Initiation of the Proof of Mechanism Study for BBT-401 in Patients with Ulcerative Colitis; Rectal Delivery of Drug to Target Site
  2. Positive FDA meetings enable Neuren to proceed with INDs for three Phase 2 trials
  3. Australia's original prolonged-release melatonin now available over the counter at pharmacies
  4. With 681 Million 5G Handsets Set to Ship in 2022, Mobile Device Vendors Scramble for Differentiation
  5. Maastricht University research finds that mealworm protein is as beneficial as milk protein
  6. 100th Elekta Unity MR-Linac goes to St George's Hospital in New Zealand
  7. Mineração Vale Verde completes construction at the Serrote copper-gold mine ahead of schedule and under budget
  8. Acclime consolidates its expansion to Australia with the rebranding of CoSec Corporate Services
  9. GROHE and American Standard announce winners of the Asia Pacific Property Awards 2021-22
  10. Singapore-based Impact Investor Heritas Capital Announces US$60M First Close of Heritas Growth Fund III to Back Asian Emerging Champions Driving Sustainable Covid-19 Recovery